Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05926934
Other study ID # 409/08.02.2022
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 16, 2022
Est. completion date November 2024

Study information

Verified date June 2023
Source University of Athens
Contact Iosif Sifakakis, Associate Professor
Phone 210 74612278
Email isifak@dent.uoa.gr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is high possibility of relapse of the lower anterior teeth after orthodontic treatment. Relapse is related with the initial orthodontic anomaly, pathology of surrounding tissues, patient's age and sex and compliance and the retention protocol applied. The options for the later are various. Permanent fixed retainers are considered of the most common ones and vastly vary based of composition. There are fixed retainers distinguished for their composition (SS, β-NiTi, fiber-reinforced composite retainers) or for their shape and dimensions (round or rectangular shape and single-strand or multi-strand respectively), and/or for the teeth they are placed on (canine and canine or canine to canine). Fixed retainers may require patient's cooperation , nevertheless debond failure rate varies between 0.1-53%. The aim of this prospective randomized clinical study is to compare failure incidents and retention effect on lower anterior teeth after orthodontic finish between three different types of fixed retainers. There will be 3 arms studied in this research: a) single strand 0.016x0.022'' β-Ti canine to canine, b) 0.028'' SS canine to canine and c) 0.027'' multi-strand twistflex canine to canine. Variables such as repeatability of failures, and undesired tooth movements will be measured. Measurements will be repeated every 3 months after patient's recruitment in this study, for one year period (12 months in total). Intraoral scans will be collected during baseline (fixed retainer insertion) and after 12 months.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date November 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years to 30 Years
Eligibility Inclusion Criteria: - Patients treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) - Patients with fixed orthodontic appliances at least between their lower first premolars - No lower anterior teeth crowding (total irregularity index score = 0) - Patients with no need of removable retention appliances on their lower teeth Exclusion Criteria: - Active caries on adjacent or lingual surfaces of lower anterior teeth - Active periodontitis - Supragingival calculus - Gum bleeding during bonding of fixed retainer - Gingival pocket depth greater than 3mm - Syndromes or other anomalies of the craniofacial complex or other mental illness - Missing or impacted teeth or other dental anomalies - Congenital anomalies/syndromes - Allergies regarding the alloys of fixed retainers - Need for chemoprevention before data collection of periodontal indexes - Diabetes - Smoking - Usage of antibiotics - Pregnancy - Participation in other clinical trials

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Experimental: Single strand ß-Ti fixed retainer
All 90 patients between 13-30 y.o. treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) on at least between their lower first premolars and with no lower anterior teeth crowding (total irregularity index score = 0) and no need of removable retention appliances on their lower teeth, were randomly assigned to one of the three experimental groups.
Experimental: SS fixed retainer
All 90 patients between 13-30 y.o. treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) on at least between their lower first premolars and with no lower anterior teeth crowding (total irregularity index score = 0) and no need of removable retention appliances on their lower teeth, were randomly assigned to one of the three experimental groups.
Experimental: Twisted fixed retainer
All 90 patients between 13-30 y.o. treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) on at least between their lower first premolars and with no lower anterior teeth crowding (total irregularity index score = 0) and no need of removable retention appliances on their lower teeth, were randomly assigned to one of the three experimental groups.

Locations

Country Name City State
Greece National and Kapodistrian University of Athens, School of Dentistry, Departments of Orthodontics Athens Attiki

Sponsors (1)

Lead Sponsor Collaborator
University of Athens

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of teeth that failed regarding the bonding strength baseline-3 months
Primary Number of teeth that failed regarding the bonding strength 3 months-6 months
Primary Number of teeth that failed regarding the bonding strength 6 months-9 months
Primary Number of teeth that failed regarding the bonding strength 9 months-1 year
Primary Repeatability of bonding strength failure per patient and per tooth baseline-3 months
Primary Repeatability of bonding strength failure per patient and per tooth 3 months-6 months
Primary Repeatability of bonding strength failure per patient and per tooth 6 months-9months
Primary Repeatability of bonding strength failure per patient and per tooth 9months-1 year
Primary Breakage of fixed retainer wires baseline-3 months
Primary Breakage of fixed retainer wires 3 months-6 months
Primary Breakage of fixed retainer wires 6 months-9 months
Primary Breakage of fixed retainer wires 9 months-1 year
Primary Space discrepancy (Little index)(in mm) baseline-3 months
Primary Space discrepancy (Little index)(in mm) 3 months-6 months
Primary Space discrepancy (Little index)(in mm) 6 months-9 months
Primary Space discrepancy (Little index)(in mm) 9 months-1 year
Primary Mandibular intercanine distance baseline-3 months
Primary Mandibular intercanine distance 3 months-6 months
Primary Mandibular intercanine distance 6 months-9 months
Primary Mandibular arch length (in mm) 9 months-1 year
Secondary Tooth rotations in lower anterior teeth baseline-3 months
Secondary Tooth rotations in lower anterior teeth 3 months-6 months
Secondary Tooth rotations in lower anterior teeth 6 months-9 months
Secondary Tooth rotations in lower anterior teeth 9 months-1 year
Secondary Extrusion in lower anterior teeth baseline-3 months
Secondary Extrusion in lower anterior teeth 3 months-6 months
Secondary Extrusion in lower anterior teeth 6 months-9 months
Secondary Extrusion in lower anterior teeth 9 months-1 year
Secondary Tip inclinations anteroposteriorly baseline-3 months
Secondary Tip inclinations anteroposteriorly 3 months-6 months
Secondary Tip inclinations anteroposteriorly 6 months-9 months
Secondary Tip inclinations anteroposteriorly 9 months -1 year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT00306813 - Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma Phase 1/Phase 2
Completed NCT01956695 - Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma Phase 2
Not yet recruiting NCT05926167 - Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recovery
Recruiting NCT03710512 - Evaluation of Early Relapse After Mandibular Lengthening Surgery
Recruiting NCT04921540 - Ingrown Toenails : Surgery Only Versus Surgery + Chemical Cauterization With TCA N/A
Not yet recruiting NCT03830827 - MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users Phase 4
Completed NCT05250765 - Comparison of Efficiency and Effectiveness of Two Types of Bonded Orthodontic Retainers: an RCT. N/A
Completed NCT05915273 - Relapse and Failure Rates Between CAD/CAM and Conventional Fixed Retainers N/A
Active, not recruiting NCT04389879 - CAD/CAM Fixed Retainers vs. Conventional Multistranded Fixed Retainers in Orthodontic Patients. Comparison of Stability, Retainer Failure Rate, Adverse Effects, Cost-effectiveness, and Patient Satisfaction. A Randomized Controlled Clinical Trial N/A
Completed NCT02145403 - Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies Phase 1/Phase 2
Completed NCT01481701 - A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma Phase 2
Recruiting NCT01941394 - Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation Phase 2
Recruiting NCT04723901 - Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia Phase 1/Phase 2
Not yet recruiting NCT04994626 - Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies Phase 2
Recruiting NCT06292364 - Comparison of Retention Characteristics of Immediate vs Delayed Retainer Delivery Using 3D Digital Model Analysis N/A
Enrolling by invitation NCT05591703 - Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
Active, not recruiting NCT00299923 - Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy Phase 3
Recruiting NCT04162041 - Topotecan Plus M6620 (VX-970) vs. Topotecan Alone in People With Relapsed Small-Cell Lung Cancer Phase 2
Recruiting NCT04228315 - Biomarkers of P. Vivax Relapse N/A